Related Experiment Video
Updated: May 19, 2026

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
Published on: March 21, 2025
Differential toxicity, conformation and morphology of typical initial aggregation states of Aβ1-42 and Aβpy3-42
Denise Galante1, Alessandro Corsaro, Tullio Florio
1Institute for Macromolecular Studies, National Research Council, 16149 Genova, Italy.
Abstract:
Among the different species of water-soluble β-peptides (Aβ1-42, Aβ1-40 and N-terminal truncated Aβ-peptides), Aβpy3-42 is thought to play a relevant role in Alzheimer's pathogenesis due to its abundance, resistance to proteolysis, fast aggregation kinetics, dynamic structure and high neurotoxicity. To evaluate the specific structural characteristics and neurotoxicity of Aβpy3-42, we separated different aggregation states of Aβ1-42 and Aβpy3-42 using fast protein liquid chromatography, isolating in both cases three peaks that corresponded to sa (small), ma (medium) and la (large) aggregates. Conformational analysis, by circular dichroism showed a prevailing random coil conformation for sa and ma, and typical β-sheet conformation for la. AFM and TEM show differential structural features between the three aggregates of a given β-peptide and among the aggregate of the two β-peptides. The potential toxic effects of the different aggregates were evaluated using human neuroblastoma SH-SY5Y cells in the MTT reduction, in the xCELLigence System, and in the Annexin V binding experiments. In the case of Aβ1-42 the most toxic aggregate is la, while in the case of Aβpy3-42 both sa and la are equally toxic. Aβ aggregates were found to be internalized in the cells, as estimated by confocal immunofluorescence microscopy, with a higher effect observed for Aβpy3-42, showing a good correlation with the toxic effects. Together these experiments allowed the discrimination of the intermediate states more responsible of oligomer toxicity, providing new insights on the correlation between the aggregation process and the toxicity and confirming the peculiar role in the pathogenesis of Alzheimer disease of Aβpy3-42 peptide.
Insights
Amyloid-beta peptide (Aβ) aggregation is central to Alzheimer's disease. This study reveals that Aβpy3-42, a modified Aβ peptide, exhibits distinct aggregation states and higher neurotoxicity compared to standard Aβ1-42.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's disease pathogenesis involves amyloid-beta (Aβ) peptides, particularly Aβ1-42.
- Modified Aβ peptides, such as Aβpy3-42, are implicated due to their unique properties.
- Understanding the structural characteristics and toxicity of different Aβ aggregation states is crucial.
Purpose of the Study:
- To characterize the structural features of different aggregation states of Aβ1-42 and Aβpy3-42.
- To evaluate and compare the neurotoxicity of these distinct Aβ aggregates.
- To elucidate the role of Aβpy3-42 in Alzheimer's disease pathogenesis.
Main Methods:
- Separation of Aβ1-42 and Aβpy3-42 aggregates (small, medium, large) using fast protein liquid chromatography.
- Structural analysis via circular dichroism, atomic force microscopy (AFM), and transmission electron microscopy (TEM).
- Neurotoxicity assessment using human neuroblastoma SH-SY5Y cells (MTT reduction, xCELLigence, Annexin V binding) and confocal immunofluorescence microscopy for internalization studies.
Main Results:
- Aβ aggregates exhibited distinct structural conformations (random coil vs. β-sheet) and morphologies.
- Aβ1-42's large aggregates (la) were most toxic, while Aβpy3-42's small (sa) and large (la) aggregates showed equal, potent toxicity.
- Aβpy3-42 aggregates were internalized more efficiently by neuronal cells, correlating with their higher toxicity.
Conclusions:
- Aβpy3-42 exhibits unique aggregation properties and enhanced neurotoxicity compared to Aβ1-42.
- Specific intermediate aggregation states of Aβ peptides are key drivers of neurotoxicity.
- These findings highlight Aβpy3-42's significant role in Alzheimer's disease pathogenesis.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology

